Texas runs out of key monoclonal antibody treatment

Posted on AllSides December 28th, 2021
From The Right

Texas has run out of sotrovimab, a key monoclonal antibody treatment against omicron, due to a national shortage.

The Texas Department of Health and Human Services said the federal government controls the distribution of the monoclonal antibodies and that it expects a new shipment in January.

"Other monoclonal antibodies have not shown to be effective against the Omicron variant, which now accounts for more than 90 percent of new cases," the department said.

The department said its infusion centers will continue to offer antibodies that are helpful for other variants of...

Read full story
Some content from this outlet may be limited or behind a paywall.

Washington Examiner

AllSides Media Bias Rating: Lean Right
AllSides Media Bias Rating: Lean Right
See full bias rating for Washington Examiner
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right